Company: HCTI
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-045994
Chunk: 154

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 3
Chunk 154
---
Item 3. Quantitative and Qualitative Disclosures
about Market Risk. 

We did not have investments and do not utilize
derivative financial instruments to manage our interest rate risks.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures
and Changes in Internal Control over Financial Reporting

Disclosure controls and procedures (as defined
in Rules 13a-15(e) and 15d-15(e)) are designed to ensure that information required to be disclosed by us in reports we file or submit
under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the appropriate time periods,
and that such information is accumulated and communicated to the Chief Operating Officer and Chief Financial Officer, as appropriate,
to allow timely discussions regarding required disclosure. We, under the supervision of and with the participation of our management,
including our Chief Operating Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures.
Based on that evaluation, our Chief Operating Officer and Chief Financial Officer concluded that the design and operation of our disclosure
controls and procedures were effective as of March 31, 2025.

Changes in Internal Control over Financial Reporting 

There were no changes to our internal control
over financial reporting during the three months ended March 31, 2025, that have materially affected, or are reasonable likely to materially
effect, our internal controls over financial reporting.

38

PART II

OTHER INFORMATION

Item 1. Legal Proceedings. 

From time to time, we are involved in routine
litigation that arises in the ordinary course of business. We are not currently involved in any claims outside the ordinary course of
business that are material to our financial condition or results of operations.

Item 1A. Risk Factors. 

As of the date of this Quarterly Report on Form
10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K , filed with the SEC on March
31, 2025. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds. 

On February 27, 2025, we entered into Securities Purchase Agreements
dated February 27, 2025 with institutional investors for the private placement of 36,190,485 units (each a, “Unit”), each
Unit consisting of one share of the our common stock